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Abstract 
Motivational processes are constantly at work to focus us on relevant stimuli for survival.  The 
mesolimbic dopamine system has been strongly linked to motivation and reward-directed 
behavior, especially in regions such as the nucleus accumbens and ventral tegmental area.  
However, the nigrostriatal (substantia nigra to neostriatum) pathway has also been implicated in 
reward and motivation. Incentive salience is the motivational value placed on cues paired with 
reward.  This study aimed to test whether increased dopamine in the neostriatum could enhance 
incentive salience of a learned cue.  Differing levels of a D1/D2 dopamine agonist cocktail were 
combined with an autoshaping paradigm as a measure of incentive salience using both 
dorsomedial and dorsolateral neostriatum cannula placements.  Results indicate that dopamine 
stimulation may increase incentive salience in the direction of predictive cues in the dorsolateral 
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  Neostriatal Dopamine Modulates Motivation: 
Incentive Salience Generation in the Neostriatum 
Motivational processes are essential for our daily lives, but they often go unnoticed.  If 
something is desired or needed, there is a good chance that a motivated attempt will be made 
toward the goal, whatever that goal may be.  Many neural mechanisms have been implicated in 
the production and execution of motivation, both consciously and unconsciously.  Classically, 
the mesolimbic dopamine system, including the nucleus accumbens and ventral tegmental area, 
has been viewed as the neural center for reward (Berridge, 2004).  However, recent evidence has 
suggested that other brain structures may play an equally important role in reward processing. 
 Throughout the last half century, it has become increasingly apparent that dopamine is 
the neurotransmitter most important for reward (Berridge, 2007; Dayan & Balleine, 2002; Wise 
2009).  However, only recently has evidence pointed to a specific role for dopamine within the 
scope of reward.  Namely, dopamine is responsible for the „wanting‟ portion of reward, rather 
than „liking‟ and, to a lesser extent, learning (Berridge, 2007; Berridge & Robinson, 1998).  
„Wanting‟ refers specifically to the incentive salience process of motivation.  Incentive salience 
is an association between natural rewards and learned stimuli that are paired in a Pavlovian 
fashion.  The reward (an unconditioned stimulus) is paired with some sort of cue (a conditioned 
stimulus), and eventually the same motivational behaviors normally directed at the reward are 
then aimed at the cue as well.  In this sense, the cue becomes „wanted‟ as much as the natural 
reward, and is attractive enough to warrant approach and consummatory behaviors normally 
directed at the reward (Berridge, 2007).  Incentive salience is an anticipatory process, with the 
reward-paired cues causing motivational responses.  These responses are locked to the moment 
of cue presentation, which is the moment that „wanting‟ can be observed. 
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 A major site of dopamine innervation is the neostriatum, often referred to as the dorsal 
striatum or caudate putamen.  It is a major crossroads of connectivity between the mesolimbic 
dopamine system and the neocortex (Thorn, Atallah, Howe, & Graybiel, 2010; Voorn, 
Vanderschuren, Groenewegen, Robbins, & Pennartz, 2004).  Along with cortical projections, 
inputs from the substantia nigra, ventral tegmental area, and nucleus accumbens all converge in 
the neostriatum (Haber & Knutson, 2010; Yin, Ostlund, & Balleine, 2008).  The neostriatum is 
traditionally viewed as a site of stimulus-response (S-R) learning, which involves the learning of 
strict responses to stimuli that can be classified as habits or rigid responses.  However, there is 
growing evidence that dopamine in the neostriatum plays a role in motivation as well. 
 Dopamine in the neostriatum has been proven necessary for motivated behaviors by 
depletion studies.  A strain of dopamine-deficient mice, which show a complete lack of 
motivation for natural rewards and must be given L-DOPA daily for survival, show a rescue in 
eating behavior, locomotion, and reward-learning with the addition of a dopamine-promoting 
virus into the center of the neostriatum.  Motivated behaviors are not rescued when the virus 
restores dopamine only to the nucleus accumbens, which may indicate that the neostriatum is 
essential for motivational processing and output while the nucleus accumbens modulates more 
particular aspects of motivation (Palmiter, 2008).  This demonstrates the importance of the 
neostriatum in the manifestation of motivated behaviors and suggests that it is sufficient for the 
integration and output of motivated behaviors carried out by the dopaminergic subcircuit. 
 Other studies have also indicated that neostriatal dopamine signaling is central to 
motivational processes.  Evidence exists in reward learning, where substantia nigra neurons fire 
with almost identical patterns to ventral tegmentum neurons in the presence of stimuli paired 
with rewards (Hollerman & Schultz, 1998).  Extracellular dopamine levels increase in the 
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neostriatum during presentation of a drug-paired cue, suggesting that the expectation of reward is 
sufficient to cause neostriatal dopamine release and has a larger role than simple motor response 
production (Ito, Dalley, Robbins, & Everitt, 2002; Robbins & Everitt, 1992).  There is evidence 
that dopamine in the neostriatum, while involved in the execution of motor activity, also has a 
role in drug-seeking behavior.  The blockade of dopamine receptors in the dorsal striatum 
inhibits cocaine-seeking behavior, with rats showing a reduced response to cocaine-paired drug 
cues (Vanderschuren, Di Ciano, & Everitt, 2006).  In humans, the neostriatum has been shown to 
act in a similar fashion.  Neostriatal dopamine release is evoked by the presentation of drug cues 
to cocaine addicts and can accurately predict feelings of drug craving (Volkow et al., 2006).  
This suggests that dopamine in the neostriatum plays an important role in drug craving, and 
subsequently the „wanting‟ portion of reward as described by incentive salience. 
 One way to model incentive salience attribution in the laboratory is the autoshaping 
phenomenon, which involves the attribution of motivated responses to a conditioned stimulus 
paired with an unconditioned stimulus.  With autoshaping, the UCS reward is delivered 
regardless of the effort put forth to receive it.  This procedure results in the attribution of a 
conditioned response to the reward cue, such as a lever presented with a cue light before a food 
reward is given.  Some animals will show approach and interactions with the cue object, while 
others are more inclined to interact with the area of reward presentation, such as a food cup.  The 
animals that interact with the cue are called sign-trackers, and those that interact with the reward 
cup are called goal-trackers.  For both of these groups behavior is locked to the cue presentation, 
which means that behaviors focused on the prepotent stimulus will only be enhanced during the 
presence of the reward-predictive cue.  Even though the two targets differ, both may express 
incentive salience. 
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A classic example of the autoshaping phenomenon is observed by Brown and Jenkins 
(1968).  Pigeons were presented with a lighted food tray that appeared for a four-second interval 
either before or after another lighted cue was presented.  The group that experienced the cue light 
before the food tray was presented (forward pairing) began to approach and peck the cue light 
(Brown & Jenkins, 1968).  Other examples of this phenomenon exist, such as a raccoon that was 
trained to put coins in a piggy bank and then rewarded as reinforcement.  Eventually, the coins 
themselves became a sort of reward for the raccoon, as he would not let go of them, even if 
reward was no longer given (Breland & Breland, 1961).  These reward-paired cues elicit a 
dopamine response, as has been illustrated in a great number of studies (Berridge, 2007; Berridge 
& Robinson, 1998; Ito et al., 2002; Robbins & Everitt, 1992). 
 When investigating the role of dopamine in the neostriatum, it is important to note the 
different responses that dopamine signaling is capable of producing.  Five types of dopamine 
receptors (D1-D5) are known, and these are divided into two families of receptors.  The D1 
family contains the D1 and D5 receptors and the D2 family contains the D2, D3, and D4 
receptors.  The striatum contains mostly D1 and D2 receptors, and D5 receptors to a lesser extent 
(Humphries & Prescott, 2010).  One known function of dopamine is the regulation of glutamate 
signaling in medium spiny neurons, which are the most prevalent neuronal population in the 
striatum (Surmeier, 2007).  This glutamate signaling in D1 receptor-expressing neurons has been 
shown to be necessary for the formation of associations between cue and reward in incentive 
learning processes (Novak et al., 2010).  Although dopamine signaling and its subsequent 
cascades are much more complicated than simple excitation and inhibition, in general D1 
receptors increase glutamate signaling and responsiveness postsynaptically (neuronal 
excitability), while D2 receptors seem to decrease downstream glutamate signaling (neuronal 
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inhibition) in the striatopallidal system through NMDA and AMPA receptor regulation 
(Palmiter, 2008; Surmeier, 2007).  Since dopamine responses are somewhat complicated, it may 
be most useful to look at the effects of general dopamine excitation in the neostriatum before 
looking at the roles of individual receptor subtypes. 
 The division between medial and lateral neostriatum has been identified by several 
studies.  This division is based on both neural connectivity and function.  In habit learning, the 
medial and ventral neostriatum show different patterns of activation during the learning of paired 
associations, and these differences also manifest themselves in the motivational output that they 
produce (Thorn et al., 2010).  The largest distinction in connectivity and function seems to be 
along the ventromedial to dorsolateral striatal gradient.  This would suggest that the dorsomedial 
and dorsolateral neostriatum also show a division of function, as the gradient is not the simple 
dorsal-ventral arrangement that was previously thought (Voorn et al., 2004).  Lesions of medial 
and lateral portions of the neostriatum produce different behavioral effects, which illustrate that a 
division of function accompanies this topographical division (Yin et al., 2008).  Additionally, 
connections between the cortex and neostriatum respond differently in terms of synaptic 
plasticity over a medial to lateral gradient.  This could indicate that anatomical differences 
underlie the differences in functional output generated by both the medial and lateral neostriatum 
(Smith, Musleh, Akopian, Buckwalter, & Walsh, 2001).  Overall, evidence is beginning to point 
to more specific areas of the neostriatum in regards to connectivity and function, so it is 
necessary to break the neostriatum down into smaller pieces to determine whether this division 
can be better explained. 
 While it is obvious that dopamine is important in reward and plays a role in the function 
of the neostriatum, there are still areas in which dopamine is poorly understood.  The following 
DOPAMINE MODULATION NEOSTRIATUM  8 
 
set of experiments will address the question of incentive salience generation in the neostriatum, 
particularly by dopaminergic activation.  To address this question, an autoshaping paradigm will 
be employed to test sign-tracking and goal-tracking behaviors in the presence and absence of a 
general dopamine receptor agonist (as well as a mu-opioid receptor agonist, used to verify an 
effect already observed in this laboratory [DiFeliceantonio & Berridge, 2010]).  In addition, fos 
immunofluorescence will quantitatively measure specific neuronal activation under vehicle and 
dopamine agonist conditions.  Most importantly, all experiments will be examining both 
dorsolateral and dorsomedial neostriatal cannulae placements to observe whether a medial/lateral 
separation of function is present in the neostriatum in respect to incentive salience processing. 
Method 
Subjects 
Female Sprague-Dawley rats, born at the University of Michigan, were housed in pairs or 
in groups of three at 21 degrees Celsius and on a 12 hour reverse light/dark cycle.  Rats were 
over three months old and between 240 and 400 grams in weight at the time of surgery.  Rat 
chow and water were provided ad libitum during housing.  All animals were handled regularly to 
accustom them to human interaction and lower their environmental stress during testing.  Animal 
studies meet all standards and were approved by the University Committee on Use and Care of 
Animals (UCUCA) of the University of Michigan, along with national regulations set by the 
National Institute of Health. 
Surgery 
The same surgical procedures were used prior to all experiments.  Rats were anesthetized 
with ketamine (80 mg/kg), xylazine (7 mg/kg), and atropine sulfate (0.04 mg/kg), along with 
carprofen (5mg/kg) as analgesic and chloramphenicol sodium succinate (60 mg/kg) to prevent 
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infection.  After administration of anesthesia, 14 millimeter steel brain cannulae were implanted 
bilaterally.  The implanted cannulae were attached to the skull with four steel screws and dental 
cement, and closed off with a stylet.  Placements for the cannulae are described in Table 1. 
Rats were monitored for one week after surgery before any behavioral testing took place.  
A dose of carprofen (5mg/kg) was administered on the first day after surgery as an analgesic.  If 
necessary, a low dose of chloramphenicol was used to prevent or improve infection.  No rats died 
before, during, or after the surgical process. 
Drug Microinjections 
All experiments (autoshaping, food intake, and fos immunofluorescence) required drug 
microinjections to administer either the tested drug or a vehicle control.  Four drug conditions 
exist for these experiments.  Both a high dose (.6mg/mL) and low dose (.3mg/mL) of a dopamine 
agonist cocktail, consisting of quinpirole (D2 agonist, Sigma Aldrich) and SKF-82958 (D1/D5 
agonist, Sigma Aldrich), were used to test the effects of general dopamine stimulation (mixture 
of these agonist cocktails is described in the Appendix A).  A 20:80 DMSO:saline mixture was 
used to allow the SKF and quinpirole to fully dissolve into solution.  The vehicle control used 
was also a 20:80 DMSO:saline mixture.  The final drug condition is a DAMGO dose, a mu-
opioid receptor agonist, dissolved in artificial cerebrospinal fluid (this dose used to verify a result 
already observed in this laboratory).  All rats used in the autoshaping and food intake 
experiments were tested under both dopamine conditions and vehicle, and most were also tested 
under a DAMGO condition.  Thus, four days of testing were usually required per animal for each 
type of experiment, with at least one day break between test days.  The fos study requires a naïve 
drug microinjection by nature, and thus each animal in the fos groups were only administered 
one drug condition. 
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Drug microinjections were administered by a microinfusion pump that allows a slow, 
steady delivery of drug into the desired brain region.  Microinjections occurred directly before 
experimentation so the drug effects could be most potent.  A dose of .5µL of drug was given 
over a two-minute span, and another minute was allowed before microinjection tubes were 
removed to ensure all drug was delivered.  The dose of .5µL means that an effective dose of 
.3µg/.5µL was given for the S/Q High dose and .15µg/.5µL for the S/Q Low dose.  After the 
microinjection was complete, a clean stylet was inserted into the cannulae and the rats 
immediately began experimentation.   
Autoshaping 
A total of 21 rats underwent autoshaping testing (ndorsomedial = 11, ndorsolateral = 10).  The 
autoshaping chambers used for the first set of experiments consisted of a 4.5 cm x 2 cm cue lever 
that would appear with a cue light and 2.9 kHz continuous noise (CS+), an identical neutral lever 
that was present at all times (CS-), and a recessed food cup (CScup), also present at all times and 
used to administer a sucrose pellet after the presentation and withdrawal of the cue lever.  Each 
cue lasted eight seconds, and twenty-five total cue presentations occurred in each experimental 
session. The inter-trial interval (time between CS+ presentations) varied between cues, but on 
average was 90 seconds.  The CS+ appeared with the cue signals, which makes it more 
associated with the prediction of the reward delivery.  The CScup is also the delivery location of 
the UCS sucrose reward, but is not directly predictive of reward because it is never retracted. 
A program was created with MedPC Software to run the series of cue presentations on a 
random interval, and all video was recorded for scoring using Sony RealShot Manager.  During 
training and testing, food was restricted to 10g chow/rat/day for the first few days and eventually 
raised to 15g chow/rat/day.  This food restriction may have increased hunger, and thus 
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motivation for the sucrose reward, but also was useful in putting the animals in the same 
homeostatic state throughout all days of testing. 
After surgery and prior to experimentation, rats were acclimated to the autoshaping 
chambers for six days.  The first day consisted of a magazine training program, which simply 
gives a cue light and sound along with the delivery of a sugar pellet into the food cup.  20 total 
pellets were delivered, which taught the rats when and where to expect a sugar pellet in the 
chambers.  The next five days consisted of autoshaping training, which consisted of the normal 
experimental procedure for all 25 cues, but in the absence of drug.  These five days were a period 
of Pavlovian Instrumental training, where the rats soon identified the cue presentation with the 
sucrose reward. 
Based on the amount of time spent interacting with the food cup or the autoshaping lever, 
rats were characterized as either sign-trackers or goal-trackers.  Sign-trackers interact more with 
the autoshaping lever during cue presentation under absence of drug, while goal-trackers interact 
more with the food cup under absence of drug.  These two classifications occurred within the 
already present conditions of cannula placement.  This left four distinct test groups, which are 
dorsomedial lever-oriented, dorsomedial cup-oriented, dorsolateral lever-oriented, and 
dorsolateral cup-oriented. 
Autoshaping Video Scoring 
Video analysis was done in slow motion and took place blind of drug condition.  When 
scoring the data, only the first, fifth, tenth, fifteenth, twentieth, and twenty-fifth CS+ 
presentations were scored and assumed to be a representative sample of the overall interactions 
that took place during the trial.  Of these scored trials, the first was omitted from the data because 
it usually consisted of behaviors that were uncharacteristic of the rat during the rest of the test 
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run, possibly due to the added stress immediately after the microinjection.  Thus, five cues were 
scored per rat in each drug condition.  In addition to the eight seconds scored during each cue, 
the eight seconds prior to each cue presentation were also scored to determine whether any 
subsequent drug effects are general or specific to the time of cue presentation. 
Scored behaviors include nibble-sniffs, slow bites, approaches to cue, and looks toward 
the opposite cue.  Latency to the cue was also measured (in seconds) from the time of cue 
presentation to the time of first contact with the lever or first movement into the food cup.  These 
behaviors were scored for both the lever and food cup, which leaves a total of 10 scored items 
per test run.  Nibble-sniffs include physical contact with either the lever or food cup by many 
small, quick bites or focused sniffing.  Slow bites involve more contact with the lever or food 
cup and are longer in duration, also concentrated to one area (whereas nibble-sniffs can be seen 
while the animal‟s head is moving from one part of the lever or cup to another).  In this sense, 
the slow bites are more concentrated to one area and involve less movement of the animal.  
Approaches are measured when the animal either moves toward a cue for the first time during 
presentation or when she switches cues during presentation.  In contrast, a look consists of visual 
contact being made with the opposite cue when already having approached the first cue, but 
without approach behavior being made to the second cue.  For example, if a rat were committing 
nibble-sniffs to the autoshaping lever then stopped, turned her head toward the food cup, but then 
continued showing consummatory behaviors toward the lever, a food cup look would be 
recorded rather than a food cup approach. 
Food Intake 
Two surgery groups were subjected to a food intake trial after autoshaping testing.  13 
rats (ndorsomedial = 6, ndorsolateral = 7) were used in this experiment.  Rats were taken off of food 
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restriction prior to experimentation, which occurred with a one-day break between drug 
conditions.  Drug microinjections with the same four conditions preceded one-hour intervals in 
food intake chambers.  These chambers are clear to allow video scoring, with each rat getting her 
own chamber.  Water was provided ad libitum in the chambers along with 20 grams of M&Ms 
and 20 grams of regular rat chow.  Three neutral wood blocks in the shape of the rat chow were 
also present as a control for focused eating rather than a simple locomotor effect.  The final 
amounts of M&Ms and rat chow were measured and recorded. 
Video scoring was again done in slow motion and blind to drug condition.  Scored eating 
behaviors were chow eating events and time spent eating, M&M eating events and time spent 
eating, and wood chew events.  Drinking bouts, food-sniffs directed at either M&Ms or chow 
(focused sniffing, but no eating), and M&M carries and chow carries (food picked up and 
brought to another part of the cage) were also recorded.  Cage crosses (front to back, or vice 
versa), treading, grooming, sleeping (bouts and amount of time), and rearing are general 
behaviors that were recorded to determine whether large locomotor effects of the drugs could be 
playing a role in the data. 
Brain Extraction for Autoshaping and Food Intake 
Brains were extracted after all sets of experimentation to check cannula placement.  Rats 
were given a lethal injection of pentobarbital (between .65mL and .80mL) and decapitated.  
After decapitation, brains were manually extracted and incubated overnight in a 10% 
paraformaldehyde solution.  After 24 hours, the brains were switched to a solution of 30% 
sucrose in .1M NaPB.  After the brains sank, which was between two and three days, the brains 
were rapidly frozen and cut into 60µm slices.  These slices were then mounted on slides and 
DOPAMINE MODULATION NEOSTRIATUM  14 
 
allowed two days to dry.  A Nissl stain colored the brain tissue, and cover glass was applied to 
keep the brains from decaying.  The Nissl stain procedure is explained in-depth in Appendix B. 
After staining and mounting, cannula placements were verified.  Data for two animals 
were excluded because of incorrect cannula placement.  Rat 6965 had a cannula placement into 
the ventricle, which forced it to be excluded from data.  Rat 7119 had a placement that was too 
far dorsal and did not cross the corpus callosum into the neostriatum, also forcing it to be 
excluded from data.  All other rats had acceptable cannula placements. 
Fos Immunohistochemistry 
A fos study was used to determine neuronal activation during drug microinjection.  The 
same surgical procedure, including placements for dorsomedial and dorsolateral neostriatum, 
were employed.  18 rats were used in the experiment, 9 dorsomedial, 8 dorsolateral, and 1 
normal.  The normal rat, used as a control, was given only screws and dental cement without 
implanted cannulae.  Of the dorsomedial placements, 3 were given vehicle, 3 S/Q Low dose, and 
3 S/Q High dose.  The dorsolateral placements consisted of 3 vehicle, 2 S/Q Low dose, and 3 
S/Q High dose.  The rats were handled five times before the date of microinjection to minimize 
fos activation due to stress rather than due to microinjection.  The naïve rats were given 
microinjections of their drug condition and sacrificed forty minutes later, which was estimated to 
be the peak time of activation for the S/Q drug conditions. 
Brains were extracted with the same procedure as previously stated, but decapitation was 
preceded by a transcardial perfusion which prepared the brains for immunohistochemistry.  In 
addition, the slicing procedure varied slightly.  Brains were sliced to 40µm, with every other 
slice being placed in one of two scintillation vials, which left two viable sets of tissue per brain 
in the event that one vial was destroyed.  The backup vial was stored in cryoprotectant at -20
o
F.  
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After incubation in primary and secondary antibody over a two day period, brains were mounted 
on slides and covered once dry.  The fluorescently labeled fos was observed under a microscope 
and transferred onto digital images to be scored.  The scored area was taken directly behind the 
center microinjection point, where less tissue damage occurred but still close enough to the 
injection point to allow drug to diffuse to that area.  For a more detailed description of the fos 
procedure, see Appendix C. 
Fos scoring took place with a grid placed upon the digital image.  Boxes down the x- and 
y-axes, along with two other axes on a 45 degree angle from x and y, were used as a scoring 
template.  Each fluorescent dot was counted as a fos positive cell, and only the fos marks in the 
boxes counted in the fos total.  These total fos counts were included in the data. 
Data Analysis and Graphing 
Data for all of the above experiments were originally entered into Microsoft Excel, where 
they were organized into relevant categories.  Data were then transferred to SPSS for statistical 
analysis.  Graphs of the data were created on Microsoft Excel and edited in Adobe Illustrator. 
Results 
Autoshaping 
 For all autoshaping data, a repeated-measures ANOVA with a Bonferonni correction on 
subsequent t-tests was applied.  An α level of .05 was used in determining whether data was 
statistically significant.  Since there were a low number of rats in each experimental group, data 
trends are also discussed as percentage of vehicle for drug conditions.  Results are reported in 
terms of S/Q Low and S/Q High stimulation for both cannula placements and in terms of 
autoshaping tendancy (lever-oriented and food-cup oriented). 
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Dorsomedial Lever-Oriented Animals.  The S/Q Low dose appears to increase 
nibblesniffs and slow bites with both the food cup and cue lever during presentation, while the 
S/Q High dose showed only an increase in nibblesniffs and slow bites with the prepotent 
stimulus, the cue lever.  These results are shown below. 
S/Q Low Dose for Dorsomedial Lever-Oriented Animals.  Data for dorsomedial lever-
oriented animals under the S/Q Low dose showed an increase in prepotent interactions (109% of 
vehicle; Mnibblesniffs = 5.88, SD = 1.39, Mslow interactions = 1.24, SD = 1.65), described as lever 
nibblesniffs plus lever slow bites, along with a slight increase in non-prepotent interactions 
(104% of vehicle; Mslow interactions = 0.04, SD = 0.09).  This accompanied a small increase in 
latency to the prepotent cue (112% of vehicle; Mlatency = 1.44, SD = 0.79) and no change in 
latency to the non-prepotent cue.  An increase in the probability of approaching both lever and 
food cup (from zero to four percent, F(2, 4) = 368.57, p < .001) was also observed, which 
follows the observed increase in interactions with both food cup and cue lever.  Overall, the S/Q 
Low dose shows an increase in nibblesniffs and slow bites focused on both the prepotent and 
non-prepotent stimulus. 
S/Q High Dose for Dorsomedial Food Cup-Oriented Animals.  The S/Q High dose 
showed a decrease in prepotent interactions (95% of vehicle; Mnibblesniffs = 4.96, SD = 1.34, Mslow 
interactions = 1.24, SD = 1.49) but an increase in non-prepotent interactions (116% of vehicle; 
Mnibblesniffs = 0.12, SD = 0.18).  Rats were slower to the prepotent cue (130% of vehicle; Mlatency = 
1.68, SD = 1.06) and quicker to the non-prepotent cue (94% of vehicle; Mlatency = 7.51, SD = 
0.68), along with being more likely to approach both cues during presentation (from zero to 12% 
probability).  Overall, the S/Q High dose shows an increase in only nibblesniffs and slow bites  
for the non-prepotent stimulus. 
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 Dorsomedial Food-Cup Oriented Animals.  The S/Q Low dose shows an increase in 
nibblesniffs and slow bites with both the prepotent and non-prepotent stimuli during cue 
presentation, while the S/Q High dose shows and increase in nibblesniffs and slow bites with 
only the prepotent stimulus. 
S/Q Low Dose for Dorsomedial Food Cup-Oriented Animals.  In dorsomedial food-cup 
oriented animals under the S/Q Low dose, a large increase in prepotent interactions (food cup) 
was observed (140% of vehicle, F(2, 4) = 3.00, p = .008; Mnibblesniffs = 3.28, SD = 1.45, Mslow 
interactions = 1.44, SD = 1.13), which accompanied a decrease in latency to the food cup (61% of 
vehicle; Mlatency = 1.77, SD = 0.84).  An increase in cue lever interactions was also seen (142% of 
vehicle; Mnibblesniffs = 0.68, SD = 0.89, Mslow interactions = 0.12, SD = 0.27) along with a decrease in 
latency to the lever (88% of vehicle; Mlatency = 6.26, SD = 1.95).  The probability of approaching 
both cues also increased from vehicle levels (from 52% to 64% probability, F(2, 4) = 41.66, p = 
.009).  Like the lever-oriented animals with a dorsomedial cannula placement, this dose showed 
an increase in nibblesniffs and slow bites with both the prepotent and non-prepotent stimuli 
during cue presentation. 
S/Q High Dose for Dorsomedial Food-Cup Oriented Animals.  For the S/Q High dose, 
prepotent interactions increased (149% of vehicle; Mnibblesniffs = 2.92, SD = 1.22, Mslow interactions = 
2.04, SD = 1.81) while latency to the food cup decreased (74% of vehicle; Mlatency = 2.14, SD = 
1.77).  Non-prepotent interactions decreased (92% of vehicle; Mnibblesniffs = 0.52, SD = 1.05, Mslow 
interactions = 0.08, SD = 0.18) as cue lever latency also decreased (90% of vehicle; Mlatency = 6.43, 
SD = 2.71).  Another large distinction from the S/Q Low dose was in the probability of 
approaching both cues during presentation, which decreased greatly (from 52% to 36% 
probability).  Unlike the lever-oriented animals with a dorsomedial cannula placement, the S/Q 
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High dose showed an increase in nibblesniffs and slow bites with only the prepotent stimulus for 
this cannula placement. 
Dorsolateral Lever-Oriented Animals.  For lever-oriented animals with a dorsolateral 
cannula placement, the S/Q Low dose increases nibblesniffs and slow bites in the direction of the 
cue lever, while also showing a decrease in these interactions with the food cup.  The S/Q High 
dose showed the opposite effect. 
S/Q Low Dose for Dorsolateral Lever-Oriented Animals.  In dorsolateral lever-oriented 
animals, the S/Q Low dose increased the number of interactions with the cue lever (118% of 
vehicle; Mnibblesniffs = 5.84, SD = 1.37, Mslow interactions = 1.4, SD = 1.21, Figure 1) while also 
decreasing latency to the lever (82% of vehicle; Mlatency = 1.18, SD = 0.49).  Interactions with the 
food cup decreased (74% of vehicle; Mnibblesniffs = 0.36, SD = 0.50, Mslow interactions = 0.2, SD = 0.28 
Figure 1), while latency increased (109% of vehicle; Mlatency = 6.55,  SD = 1.74).  The probability 
of approaching both cues during cue presentation remained at vehicle level.  Overall, the cue 
lever gains interactive behavior from the rat while the food cup loses these interactions. 
S/Q High Dose for Dorsolateral Lever-Oriented Animals.  For the S/Q High dose, 
interactions with the food cup increased (114% of vehicle; Mnibblesniffs = 0.2, SD = 0.45, Mslow 
interactions = 0.2, SD = 0.45, Figure 2), while interactions with the cue lever decreased (31% of 
vehicle, Mnibblesniffs = 5.72, SD = 1.60, Mslow interactions = 1.32, SD = 1.49, Figure 2).  Latency did 
not change from vehicle for the cue lever, while it increased for the food cup (116% of vehicle; 
Mlatency = 6.98, SD = 2.29).  The S/Q High caused increased interactions with the food cup and 
fewer with the cue lever. 
 Dorsolateral Food-Cup Oriented Animals.  For food-cup oriented animals with a 
dorsolateral cannula placement, the S/Q Low dose showed an increase in nibblesniffs and slow 
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bites with the cue lever and a decrease in these interactions with the food cup.  The S/Q High 
dose showed a general increase in these interactions with both cues. 
S/Q Low Dose for Dorsolateral Food-Cup Oriented Animals.  In dorsolateral food-cup 
oriented animals, the S/Q Low dose promoted a decrease in interactions with the food cup (82% 
of vehicle; Mnibblesniffs = 1.25, SD = 0.53, Mslow interactions =0.45, SD = 0.5, Figure 2) while causing 
increases in cue lever interactions (130% of vehicle; Mnibblesniffs = 0.05, SD = 0.1, Figure 2).  
Latency to the food cup increased greatly (186% of vehicle; Mlatency = 3.09, SD = 1.01) while it 
decreased slightly for the food cup (95% of vehicle; Mlatency = 6.97, SD = 1.26).  The effect seen 
here is a decrease in sniffing and biting behavior of the food cup and an increase in this behavior 
toward the cue lever, an effect that is very similar to the S/Q Low dose in lever-oriented animals 
with a dorsolateral cannula placement. 
S/Q High Dose for Dorsolateral Food-Cup Oriented Animals.  For the S/Q High dose, 
an increase in interactions with the food cup was seen (111% of vehicle; Mnibblesniffs = 1.6, SD = 
1.10, Mslow interactions = 0.8, SD = 0.71) along with a decrease in interactions with the cue lever 
(90% of vehicle; Mnibblesniffs = 0.1, SD = 0.2).  Latency to both cues increased for the high dose 
(lever = 109% of vehicle; Mlatency = 8, SD = 0; food cup = 118% of vehicle; Mlatency = 1.96, SD = 
1.52).  Overall, the S/Q High dose showed a general increase in interactions with both cue lever 
and food cup. 
All Dorsomedial Animals.  Since results for prepotent and non-prepotent interactions 
were similar for the dorsomedial placement, they were grouped together.  The data can be better 
explained in terms of the overall effect in this placement, rather than distinguishing between 
sign-trackers and goal-trackers.  For the dorsomedial neostriatum cannula placement, interactions 
with the prepotent stimulus (cue lever for sign-trackers, food cup for goal-trackers) increased for 
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the S/Q Low dose (142% of vehicle, F(2,9) = 2.751, p = .002, Figure 3), as did the number of 
interactions with the non-prepotent stimulus (131% of vehicle; Mnon-prepotent interaction = 1.48, SD = 
1.01, Figure 3).  A slightly decreased latency to both the prepotent cue (97% of vehicle; Mlatency = 
1.77, SD = 0.84) and non-prepotent cue (93% of vehicle; Mlatency = 6.26, SD = 1.95) was also 
observed.  The probability of approaching both cues was also increased (52% of trials to 64% of 
trials, F(2,9) = 159.648, p < .001). 
All Dorsolateral Animals.  Since the effect shown by both dorsolateral lever-oriented 
animals and dorsolateral food-cup oriented animals was very similar in terms of cue lever and 
food cup interactions, data was combined to observe the overall area effect.  The effect produced 
by the S/Q Low dose is better described in terms of lever interactions and cue interactions, rather 
than prepotent/non-prepotent interactions.  In this area, lever interactions increased (118% of 
vehicle; Mlever interactions = 4.33, SD = 3.57, Figure 4) while latency to the cue lever did not change 
from vehicle level (Mlatency = 3.76, SD = 3.34,).  In contrast, a decrease in food cup interactions 
(86% of vehicle; Mfood cup interactions = 1.13, SD = 1.32) is accompanied by a large increase in 
latency (497% of vehicle; Mlatency = 5.01, SD = 2.95). 
Autoshaping: Combining Placements to Determine Effects.  Since the dopamine 
agonist cocktail used in this study had been previously unused, it was necessary to use both the 
high dose and low dose to see which one produced a more reliable effect.  When referencing the 
above results, the S/Q Low dose appears to produce the more reliable result.  Therefore, the 
focus of the discussion will be on those results, along with possible explanations for the 
discrepancies between doses.  As an overall effect, combining all animals with a dorsomedial 
cannula placement shows an increase in nibblesniffs and slow bites with both the prepotent and 
non-prepotent stimulus for the S/Q Low dose.  That contrasts with the dorsolateral placement, 
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where animals showed an increase in nibblesniffs and slow bites with the only autoshaping lever, 
along with a decrease in these interactions with the food cup. 
Fos immunohistochemistry 
 Fos counts performed on images of the fluorescently labeled tissue yielded results that 
differed slightly from the autoshaping data.  Counts were performed on a grid of ten 0.05mm x 
0.05mm boxes along both the x- and y-axis and at 45
o
 to each axis.  For animals with a 
dorsomedial placement, the S/Q Low dose remained at vehicle levels of activation (100% of 
vehicle, Figure 5) for almost all distances from the center of the grid, up to the final scored point 
at 0.50mm from center.  However, a much higher level of activation was recorded for the S/Q 
High dose in the dorsomedial animals (between 175% and 225% of vehicle activation at all 
points, Figure 5).  Animals with a dorsolateral placement displayed similar levels of activation 
up to 0.20mm from center (about 125% to 150% of vehicle, Figure 6) for both S/Q doses, but 
showed differing activation at more distant points.  While the S/Q Low dose continued to show 
activation at 125% of vehicle and less at 0.50mm, the S/Q High dose increased activation for 
distant points, up to around 200% of vehicle at 0.50mm (Figure 6).  This data shows an 
unexpected effect when the autoshaping data is referenced, as the S/Q Low dose showed more 
behavioral effects during autoshaping but the S/Q High dose showed more fos activation. 
Food Intake 
 S/Q Low Dose for the Dorsomedial Placement.  For animals with a dorsomedial 
cannula placement, the S/Q Low dose elicited increases in both eating and locomotor behaviors.  
The amount of M&Ms eaten (in grams) did not show a change from vehicle (MM&M eaten = 7.38, 
SD = 2.31) and the number of M&M eating bouts decreased only slightly (MM&M bouts = 14, SD = 
1.41), as did the total amount of time spent eating (MM&M time = 561.5, SD = 34.65).  However, 
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the number of focused M&M sniffs increased greatly (233% of vehicle; MM&M sniff = 22.5, SD = 
10.61, Figure 7).  These effects accompanied large increases in cage crosses (158% of vehicle; 
Mcage cross = 75, SD = 19.80) and rearing events (140% of vehicle; Mrear = 146, SD = 67.88).  For 
the S/Q Low dose, focused sniffs toward the M&Ms increased, as did the locomotor response to 
the drug. 
S/Q High Dose for the Dorsomedial Placement.  For the S/Q High dose, very similar 
effects were seen.  The amount of M&Ms eaten did not change from vehicle (MM&M eaten = 7.25, 
SD = 1.33) and M&M eating bouts decreased slightly (83% of vehicle; MM&M bouts = 12.5, SD = 
0.71).  Total time spent eating did not change from vehicle (MM&M time = 535, SD = 149.91), but 
focused sniffs at the M&Ms doubled (199% of vehicle; MM&M sniff = 29, SD = 0).  Again, cage 
crosses (182% of vehicle; Mcage cross = 86.5, SD = 10.61) and rearing bouts (141% of vehicle; 
Mrear = 146.5, SD = 58.69) increased.  For the S/Q High dose, focused sniffs toward M&Ms 
doubled from vehicle levels, and the locomotor response to the drug also increased. 
 S/Q Low Dose for the Dorsolateral Placement.  Animals with a dorsolateral cannula 
placement showed a different response to the dopamine agonist drugs.  For the S/Q Low dose, 
there was no change from vehicle in the amount of M&Ms eaten (MM&M eaten = 8.29, SD = 2.31), 
the number of M&M eating bouts (MM&M bouts = 12, SD = 1.73), or the amount of time spent 
eating M&Ms (MM&M time = 749, SD = 143.45).  M&M sniffs decreased slightly (92% of vehicle; 
MM&M sniff = 15.67, SD = 4.51, Figure 7), as did rearing (88% of vehicle; Mrear = 59.33, SD = 
0.58).  An increase in cage crosses was seen (117% of vehicle; Mcage cross = 37, SD = 5.29).  For 
the S/Q Low dose, no large change from vehicle was seen for M&M related interactions and a 
mixed effect was seen for locomotor behaviors. 
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 S/Q High Dose for the Dorsolateral Placement.  For the S/Q High dose, the total 
amount of M&Ms eaten decreased (79% of vehicle; MM&M eaten = 6.46, SD = 3.22), as did the 
number of M&M sniffs (88% of vehicle; MM&M sniff = 15, SD = 1.42).  M&M eating events 
increased slightly (111% of vehicle; MM&M bouts = 13, SD = 4.24), as did the total time spent 
eating M&Ms (106% of vehicle; MM&M time = 815.5, SD = 204.35).  Locomotor activities did not 
differ much from vehicle, but did increase very slightly.  Cage crosses (106% of vehicle; Mcage 
cross = 33.5, SD = 6.36) and rears (108% of vehicle; Mrear = 73, SD = 9.90) showed these slight 
increases.  For the S/Q High dose, results did not differ strongly from vehicle for both M&M 
related interactions or locomotor behaviors. 
Discussion 
The data presented here demonstrate a motivational role for dopamine in the neostriatum.  
The most interesting pieces of evidence are in the autoshaping results for the S/Q Low dose of 
both dorsomedial and dorsolateral animals.  In all animals with a dorsolateral cannula placement, 
interactions with the cue lever increased while interactions with the food cup decreased.  In 
addition, animals were quicker to the cue lever and slower to the food cup under dopamine 
stimulation.  This demonstrates a shift in focus to the predictive cue, the lever, during 
presentation.  For the dorsomedial cannula placement, all animals (sign-trackers and goal-
trackers) showed an increase in interactions with both the cue lever and the food cup.  This is a 
more general increase, not just limited to the predictive stimulus.  A decrease in latency to both 
cues was also seen for this placement.  Together, these results may indicate that dopamine in the 
dorsomedial neostriatum may prime a more general motivated state for obtaining rewards, while 
dopamine in the dorsolateral neostriatum seems to increase incentive salience in the direction of 
the predictive cue. 
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The food intake experiment also gives evidence for incentive salience generation by 
dopamine signaling in the neostriatum.  The increased number of focused sniffs on the M&Ms 
under the S/Q Low condition in the dorsomedial placement indicates a heightened anticipatory 
response of the M&M reward itself, which is exactly what would be predicted by incentive 
salience.  The sight of the M&M is a food cue and generates a cue-paired response, which only 
takes place prior to consumption.  The anticipatory nature of the sniff does not transfer to actual 
consumption of the M&M, as is seen in the results (no change in amount of M&Ms eaten for the 
dorsomedial placement), because it is associated only with the „wanting‟ portion of the reward.  
M&M sniffs are comparable to nibblesniffs and slow bites on the cue lever in the autoshaping 
portion of the study because they both signal the upcoming availability of reward.  However, the 
consummatory phase is not initiated because these behaviors are specific to the cue, not the 
reward. 
 With previous research suggesting a more goal-oriented role for the dorsomedial 
neostriatum and an S-R role for the dorsolateral neostriatum, it was interesting to note that the 
data obtained in this study did not fully support these ideas.  Yin et al. speak of the dorsolateral 
neostriatum as being an area of strict S-R habit production (Yin et al., 2008).  If this were the 
case, then S-R habits should have been strengthened with increased dopamine levels.  Sign-
tracking animals did show an increased number of interactions with the cue lever and fewer with 
the food cup, which would be consistent with an S-R hypothesis; however, goal-tracking animals 
did not show a similar strengthening of their prepotent stimulus – they also showed an increase 
in lever interactions and a decrease in food cup interactions.  These data together show that 
rather than increase habitual action, incentive salience is instead increased, demonstrated by a 
flexible change in behavior.  The rats seem to experience a shift in focus away from the food cup 
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and in the direction of the predictive cue under dopamine stimulation of the dorsomedial 
neostriatum. 
While a distinct shift in focus was not seen under increased dopamine in the dorsomedial 
neostriatum, an increase in interactions with both the prepotent and non-prepotent cues was seen 
along with decreased latencies to both cues.  This could indicate that an increased motivational 
state was primed by dopamine, which made both stimuli more attractive.  General motivated 
behaviors are restored to dopamine-deficient mice when a dopamine promoting virus is injected 
into the dorsomedial neostriatum, but less effective with an injection into the dorsolateral 
neostriatum (Palmiter, 2008).  The non-specific activation observed in this study may also 
underline the more general role of rescuing motivation for many different processes, which in the 
Palmiter study include feeding, locomotion, and reward-based learning (Palmiter, 2008). 
A study by Volkow et al. involving video presentation of drug cues to cocaine-addicted 
humans showed that the cues themselves are sufficient to elicit dopamine release in the 
neostriatum, especially along the nigrostriatal pathway.  The study speaks mostly of drug 
“craving” as a correlate of “wanting” and suggests that it is the main reason for actions used to 
obtain the drug reward (Volkow et al., 2006).  Much like the Volkow study, this study sees the 
moment of cue presentation as the time when dopamine release has its largest noticeable effect in 
the neostriatum.  The prepotent stimulus is comparable to a drug cue, and the increased craving 
resembles incentive salience (Volkow et al., 2006).  Even though drug cues for human addicts 
are very different from reward-paired cue presentations in this study, they both relate to the 
moment of reward anticipation and thus may include a common neural pathway.  Recently, 
another form of cue-based activation has been associated with the neostriatum.  Striatal 
dopamine signaling increases in response to food cues in humans and to a greater extent in obese 
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humans (Stice, Yokum, Burger, Epstein, & Small, 2011; Volkow, Wang, & Baler, 2011).  Over-
activation of the neostriatum can also be observed in children that have a high risk for 
developing obesity (Stice, et al., 2011).  This increase in eating behavior caused by striatal 
activity correlates to the increase in motivated behaviors shown toward the predictive cues in this 
study.  Dopamine modulation in the neostriatum has obvious ties to addictive behavior, both for 
drugs and food, and may be an important predictor of susceptibility to addiction later in life. 
 One seemingly contradictory result of this study is the enhanced level of neostriatal fos 
activation seen with the S/Q High dose when compared with the S/Q Low dose.  With the 
autoshaping data showing an increased number of interactions with the prepotent stimulus in the 
dorsomedial placement for the S/Q Low dose, along with a more consistent pattern of activation, 
it was strange that the S/Q High dose elicited a stronger level of fos activation.  This could be 
explained by the type of activation the dopamine agonist cocktails provided.  It is possible that 
the activation of D1 and D2 receptors has a different overall response at low or high levels of 
activation.  SKF-82958 is a D1/D5 receptor agonist, which has been shown to cause neuronal 
activation of downstream neurons, while quinpirole is a D2 receptor agonist, which causes 
neuronal depression (Palmiter, 2008; Surmeier, 2007).  It has been demonstrated that D1 
activation produces a large activation of the fos protein, while D2 stimulation does not (Paul, 
Graybiel, David, & Robertson, 1992).  The heightened levels of the D1 agonist in the high dose 
may have been sufficient to raise fos levels independently of the D2 stimulation.  It is also 
possible that the increased fos activation seen was due to an overall increase in dopamine 
receptor activation and their subsequent signaling cascades, but the competition between the D1 
and D2 response systems lowered the motivational response as observed in the results. 
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The discrepancy in motivational output based on overall dopamine stimulation may be 
explained by the activation of both direct and indirect dopamine pathways.  The direct pathway, 
activated by D1 receptor stimulation, seems to have an excitatory function throughout a cortico-
basal ganglia loop.  In contrast, the indirect pathway, marked by D2 activation, has an inhibitory 
function through the same kind of loop (Graybiel, 2000).  When activated simultaneously, these 
pathways may balance each other in some aspect but also have unexpected effects that influence 
the overall motivational output generated in the neostriatum.  In this experiment, D1 receptor 
activation by SKF-82958 may be more potent in the S/Q Low dose while quinpirole activation of 
D2 receptors may function more efficiently at a higher concentration, which could cause internal 
competition to determine the absolute activation or inhibition that dopamine signaling will elicit.  
A good way to test this hypothesis would be to test each drug individually.  This would also help 
clarify the effects seen in the autoshaping portion of the experiment and give more specificity to 
the role of each dopamine receptor subtype in the neostriatum. 
As seen in the results of this study and as reported by numerous other studies, a division 
of function occurs along the medial/lateral gradient of the neostriatum (Faure, Haberland, Condé, 
& El Massioui, 2005; Thorn et al., 2010; Yin et al., 2008).  However, this is the first study that 
has specifically targeted dopamine modulation along this gradient in terms of the incentive 
salience process.  Because of this, the evidence obtained from this study was intriguing enough 
to warrant a more in-depth look with future studies.  Another gradient that would be useful to 
study is the rostral/caudal gradient of the neostriatum, which may show a similar distinction of 
activation between the two areas.  One study has investigated the role of the posterior medial 
neostriatum in regards to the learning of goal-directed actions, which could be initiated there 
(Yin, Knowlton, & Balleine, 2005).  This division could be measured with an autoshaping study 
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as well, which would help determine whether the posterior medial neostriatum differs from its 
more anterior portion in respect to motivational processing. 
Studies that measure a potential motivational role for dopamine in the neostriatum have 
interpreted the processes seen as goal-directed behaviors or reward-based habit learning rather 
than assigning a concrete motivational role, such as incentive salience, to the neostriatum (Ito et 
al., 2002; Palmiter, 2008; Volkow et al., 2006). However, this study presents evidence that the 
motivational process of incentive salience may be directly influenced by dopamine receptor 
activation in the neostriatum.  This result opens up an exciting area of research, as the 
motivational role of dopamine in the neostriatum is largely unstudied.  It would be beneficial to 
replicate this study with more specificity; first, at a larger scale, and then with split conditions for 
D1/D5 receptor activation and D2 receptor activation.  Another possible separation of function 
may occur along the rostral/caudal gradient of the neostriatum, so further division of the 
neostriatum may prove useful in determining specific areas of motivational functioning. 
While this study helps identify the neostriatum as a brain region that should be more 
closely studied in a motivational sense, it only begins to identify the motivational functions that 
could be seen there.  Debates about the role of dopamine are still occurring, and further 
implicating the neostriatum in motivational responding contributes to the debate.  The 
nigrostriatal pathway is now considered by several studies to be a possible contributor to the 
same incentive processes that the mesolimbic dopamine system has been attributed (Berridge & 
Robinson, 1998; Faure et al., 2005; Wise, 2009).  Understanding the functions of dopamine, 
especially in the motivational sense of incentive salience, is important because of its correlation 
with addictive behavior.  Drug cues can elicit a dopamine response in the neostriatum, which in 
turn may indicate possible chance of relapse or further drug-seeking behavior (Ito et al., 2002; 
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Vanderschuren et al., 2006; Volkow et al., 2006).  Along the same line, binge eating is another 
possible result of dopamine activation caused by cue presentation (Stice et al., 2011).  The fact 
that both of these pathways both show increased dopamine in the neostriatum indicates that a 
common mechanism may contribute to drug addiction and food addiction.  Targeting cue-
specific dopamine release in the neostriatum could possibly lower the likelihood of a drug- or 
food-seeking response to normally predictive stimuli.  As the neural circuits that determine 
motivational responses to predictive stimuli become better understood, it will become possible to 
target specific aspects of the pathway and lower the conditioned response.  Perhaps the 
framework of this experiment, along with the known anatomical relationships of the neostriatum, 
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Cannula Placement (Millimeters from Bregma) 
 
Placement  Anterior/Posterior Medial/Lateral Dorsal/Ventral 
 
______________________________________________________________________________ 
Dorsomedial  +1.0   +/- 1.8 - 1.9  -3.0 
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Figure 1.  Illustrates the increase in cue lever interactions and decrease in food cup interactions 
as seen in lever-oriented animals with a dorsolateral cannula placement.  Under the S/Q Low 
condition, interactions with the cue lever increased (118% of vehicle; Mnibblesniffs = 5.84, SD = 
1.37, Mslow interactions = 1.4, SD = 1.21) while interactions with the food cup decreased (74% of 
vehicle; Mnibblesniffs = 0.36, SD = 0.50, Mslow interactions = 0.2, SD = 0.28).  This result shows an 
increase in focus for the prepotent stimulus (the cue lever) and may indicate an increased 
„wanting‟ of the predictive stimulus. 
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Figure 2.  Illustrates the Increase in cue lever interactions and decrease in food cup interactions 
for food cup-oriented animals with a dorsolateral cannula placement.  Cue lever interactions 
increased under the S/Q Low dose (130% of vehicle; Mnibblesniffs = 0.05, SD = 0.1) while food cup 
interactions decreased (82% of vehicle; Mnibblesniffs = 1.25, SD = 0.53, Mslow interactions =0.45, SD = 
0.5, Figure 2).  This illustrates a shift in focus from the food cup to the cue lever, possibly 
indicating that the predictive stimulus becomes more „wanted‟ with dopamine transmission. 
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Figure 3. Illustrates the increases seen for interactions with both the prepotent and non-prepotent 
cues for the S/Q Low dose in animals with a dorsomedial cannula placement.  Interactions with 
the prepotent cue (142% of vehicle, F(2,9) = 2.751, p = .002) show that an increased incentive 
value may have been evoked upon cue presentation.  However, this increase is not specific to the 
prepotent stimulus, as interactions with the non-prepotent stimulus also show an increase (131% 
of vehicle; Mnon-prepotent interaction = 1.48, SD = 1.01).  Dopamine in the dorsomedial neostriatum 
may increase general motivational state rather than focus on the prepotent stimulus or shift to the 
predictive stimulus. * denotes p < .05. 




Figure 4.  Illustrates the overall shift in focus from food cup to cue lever for all animals with a 
dorsolateral cannula placement under the S/Q Low condition.  Focus was transferred from the 
prepotent stimulus to the non-prepotent stimulus for food cup oriented animals, whereas lever-
oriented animals showed an increased number of interactions with their prepotent stimulus only 
(118% of vehicle; Mlever interactions = 4.33, SD = 3.57).  This shift in focus shows an increase in 
„wanting‟ of the predictive stimulus, the cue lever. 
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Figure 5. Illustrates the trend of fos activation caused by the S/Q High and S/Q Low doses in 
animals with a dorsomedial cannula placement.  At all points from the microinjection center, fos 
activation levels remained close to vehicle levels for the S/Q Low dose.  That contrasts with the 
S/Q High dose, which caused all points from the microinjection center to show close to 200% 
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Figure 6. Illustrates the trend of fos activation caused by the S/Q High and S/Q Low dose for 
animals with a dorsolateral cannula placement.  Up to about .20mm from the microinjection 
center, both the S/Q High and S/Q Low doses showed similar fos activation (125-150% of 
vehicle levels).  However, at points further from the microinjection center, the S/Q High dose 
reaches levels of between 175 and 225% of vehicle levels, while the S/Q Low dose remains near 
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Figure 7.  Illustrates the increased number of focused sniffs on the M&Ms during the food intake 
experiment.  For the S/Q Low dose in animals with a dorsomedial cannula placement, M&M 
sniffs increased greatly (233% of vehicle; MM&M sniff = 22.5, SD = 10.61).  However, no change 
from vehicle levels of activation were observed for animals with a dorsolateral cannula 
placement under the S/Q Low dose (92% of vehicle; MM&M sniff = 15.67, SD = 4.51).  This is 
another example of anticipatory behavior being shown toward a cue.  However, the lack of 
change from vehicle for animals with a dorsolateral placement may indicate that the method of 


















Mixture of Drugs 
 
To get a drug that activated both D1/D5 and D2/D3 dopamine receptors, a mixture of quinpirole 
and SKF-82958 was created.  The following procedure details the mixture of the drugs into a 
high and low dose. 
1. 5mg SKF-82958 dissolved in 5mL of 1:4 DMSO:saline solution, resulting in a 1:1 
mixture of drug to vehicle. 
2. 10mg quinpirole dissolved in 5mL of 1:4 DMSO:saline solution, resulting in a 2:1 
mixture of drug to vehicle. 
3. In a single vial, .6mL of the SKF-82958 solution was mixed with .3mL of the quinpirole 
solution, along with .1mL vehicle (1:4 DMSO:saline) to bring the solution to 1mL.  This 
solution contains .3mg SKF-82958 and .3mg quinpirole, giving a total concentration of 
.6mg of drug per 1mL solution. 
4. This same concentration was diluted to half strength by adding another 1mL vehicle, 
which halved the concentration to .15mg SKF-82958 and .15mg quinpirole, giving a total 
concentration of .3mg of drug per 1mL solution. 
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Appendix B 
Nissl Stain Procedure 
The Nissl stain used to mark the sliced tissue was performed on all extracted brains of the 21 
non-perfused animals.  Sliced tissue was first mounted on slides and allowed at least two days to 
dry.  The completed procedure resulted in a blue stain that allowed the brains to be easily viewed 
under simple magnification, which was used to map out the sites of microinjection in each 
animal.  The procedure is as follows: 
1.   5 minute incubation in Cresyl Violet. 
2.   Dip twice in distilled water to remove excess cresyl violet. 
3.   30 second incubation in 50% ethanol solution. 
4.   30 second incubation in 75% ethanol solution. 
5.   30 second incubation in 90% ethanol solution. 
6.   1 minute incubation in 100% ethanol solution. 
7.   1-2 minute incubation in Xylenes. 
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Appendix C 
Fos Immunohistochemistry Procedure 
After the testing procedure, perfusions, and tissue sectioning, the following procedure was used 
for fos immunofluorescence.  For each brain, the following chemicals and antibodies were used: 
 
400µL Normal Donkey Serum (Jackson ImmunoResearch, 017-000-121) 
20µL 10% Sodium Azide (Sigma-Aldrich, 438456) 
4µL 1:10 dilution (w/NAPB rinse) c-Fos goat polyclonal IgG (Santa Crus 
Biotechnology, SC-52-G) 
8µL Alexa Fluor 488 donkey-anti-goat (Invitrogen, A11055) 
4 drops Image-iT FX signal enhancer (Invitrogen, I36933) 
 
In addition, NaPB and Triton rinses were also used.  The first day of the procedure consisted of 
three 10 minute rinses of the tissue, the first two being NaPB and the third being Triton rinse.  
The tissue was then placed into scintillation vials with 5% primary antibody pre-block for 30 
minutes.  Tissue was incubated overnight at 4
o
C in new scintillation vials containing the primary 
antibody solution.  All of the above steps were accompanied by a shaker at 30 RPM. 
 
The second day began with three 10 minute Triton rinses.  A 5% secondary antibody pre-block 
was prepared and the tissue was placed in it for 30 minutes.  The Tissue was then added to the 
secondary antibody solution (Alexa Fluor 488 donkey-anti-goat) along with two drops of signal 
enhancer, and the tissue was then incubated for 2 hours.  Three more 10 minute Triton rinses 
followed immediately, and the tissue was mounted after the final rinse.  All of the above steps 
were also accompanied by a shaker at 30 RPM. 
